Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The SCFMAX2 E3 ubiquitin ligase complex is a multi-subunit enzyme in plants that plays a central role in the perception and transduction of strigolactone (SL) and karrikin (KAR) signals (Martín-Fontecha et al., 2024). It consists of the scaffold protein Cullin1 (CUL1), the adaptor protein Skp1 (ASK1 in Arabidopsis), and the F-box protein MAX2 (More Axillary Growth 2), which provides substrate specificity (Stirnberg et al., 2007). Upon binding of strigolactones to the receptor DWARF14 (D14), the receptor undergoes a conformational change that promotes its interaction with the SCFMAX2 complex (Tal et al., 2022). This leads to the polyubiquitination and subsequent 26S proteasome-mediated degradation of transcriptional repressors such as SMXL6, SMXL7, and SMXL8 (Martín-Fontecha et al., 2024). This degradation relieves the repression of downstream genes, thereby regulating various aspects of plant architecture, including shoot branching, root development, and interactions with soil microbes (Tal et al., 2022). In agriculture, this complex is a target for developing strigolactone analogs to induce "suicidal germination" of parasitic weeds like Striga, which cause significant crop losses (Biorxiv, 2024). The complex also integrates signals from other hormones like abscisic acid and auxin to optimize plant growth under varying environmental conditions (Choi et al., 2014).
Ligand-induced ubiquitination and proteasomal degradation of transcriptional repressors
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skp1-Cullin1-F-box MAX2 E3 ubiquitin ligase complex (SCF(MAX2)).